The Welsh Government Deputy Minister for Farming and Food, Rebecca Evans, has officially opened the new Wales Veterinary Science Centre.
The centre, which is located on the site of the former Animal and Plant Health Agency's (APHA) Veterinary Investigation Centre, has been established by Iechyd Da, a consortium of independent veterinary practices based in Wales together with Welsh Lamb and Beef Producers Ltd, and Aberystwyth University.
Iechyd Da was recently appointed by APHA as a third party provider to deliver expert post-mortem examinations of new and re-emerging diseases of farm animals. The service has been operational since April 2015.
Deputy Minister Rebecca Evans AM said: "I am pleased to officially open the Wales Veterinary Science Centre, which will significantly strengthen and enhance the important contribution the veterinary profession makes to rural life in Wales and raises standards of animal health and welfare. It will also bolster the rural economy by securing technical jobs for the area, benefit the wider economy by supporting our farming communities, and be an asset to the UK by contributing valuable data to the surveillance network."
Professor Christianne Glossop, Chief Veterinary Officer for Wales said: "The Centre will have a significant role in the protection of animals in Wales and will provide an important contribution to a successful and resilient farming industry, reflecting the essential role of the veterinary profession in Wales."
Phil Thomas, Director of Iechyd Da said: "Iechyd Da now looks forward to building on the post-mortem provision already available so that we can provide a range of services, from running training courses for animal keepers to dissection classes for students, continuous professional development for practicing vets, and supporting disease eradication schemes. The vision is of a One Health institute that recognises the interlocking, overlapping relationships between people, livestock, the wildlife and the environment around us."
Richard Irvine, Head of Scanning Surveillance and the Surveillance Intelligence Unit at the Animal and Plant Health Agency (APHA) said: "I look forward to APHA working in close partnership with the Wales Veterinary Science Centre to provide expert diagnostic support and surveillance intelligence for veterinary practices and farmers in Wales. Only by working together can we create an effective disease surveillance network, and I urge farmers and vets in Wales to make use of the considerable expertise that exists within the Wales Veterinary Science Centre and APHA."
Dechra Veterinary Products has launched a new CPD programme covering Feline Hyperthryoidism, Canine Hyperadrenoncorticism and Otitis Externa.
The CPD is available both as face-to-face sessions, and online at http://www.dechra.com/
The face-to-face sessions are taking place at various locations throughout the country and run until the end of June 2011. There is no charge for veterinary surgeons and nurses to attend, and each session counts as two hours CPD.
The Feline Hyperthyroidism CPD session will cover pathophysiology, clinical signs, diagnosis and treatment options. The Hyperadrencorticism CPD will focus on the diagnosis and treament of hyperadrenocorticism. The Otitis Externa CPD event will focus on the approach to acute cases, with subjects including ear anatomy and physiology, causes of otitis externa and treatments available. Two cases studies, developed in association with Peter Forsythe, an RCVS Recognised Specialist in Veterinary Dermatology, will provide practical advice on how to manage dogs with otitis externa in practice.
To find out more about Dechra's CPD sessions or reserve places, call Lisa Isherwood on 01939 211 200.
Life Technologies Animal Health has announced the launch of a new qPCR test to improve the diagnosis of mastitis and respiratory disease caused by Mycoplasma bovis.
According to the company, the TaqVet Mycoplasma Bovis (M. bovis) polymerase chain reaction (PCR) kit is based on a new target gene in the M. bovis genome and thus can distinguish better between infections caused by M. bovis and M. agalactiae - so there is less risk of false positive results and improved sensitivity and specificity.
The test is based on real-time PCR technology, and delivers results in two and a half hours.
Eric Sellal, Head of Animal Health EMEA at Life Technologies said: "The improved sensitivity of this new test means that veterinarians will be able to monitor dairy herds for sub-clinical infection using samples from the bulk tank. And of course it can also be used to diagnose mycoplasma infection in individual cases of clinical mastitis and respiratory disease."
Life Technologies says the test system incorporates a number of other improvements which simplify and speed up processing in the laboratory, including automatic extraction using magnetic bead technology.
It is estimated that bovine pneumonia costs the European industry around 500million Euros each year, with 30% accounted for by M. bovis. Other diseases associated with the organism include mastitis and arthritis.
Mycoplasma is slow and difficult to culture in the laboratory and current antibiotic treatment is not very cost-effective. Therefore, prevention is a cornerstone of M. bovis management.
The TaqVet Mycoplasma Bovis PCR kit will be made available in other EU countries and via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
All entrants to the survey will also be able to enter a draw to win a £50 Amazon voucher.
Jenny Langridge (pictured), Editor of Veterinary Woman, said: “This is our third annual survey and we are seeking the opinions of both Veterinary Woman readers and the wider professions to highlight the key issues affecting women in the veterinary sector.
"We’re not just asking questions, we’re offering veterinary professionals a chance to take part in an ongoing conversation about the very real issues that women face in the veterinary workplace.
"The more diverse the information we can collate about these topics, the more we can work towards achieving changes that help for women to thrive in the professions.”
All data and responses will remain strictly anonymous.
https://bit.ly/vet-woman-readership-survey
Launching this spring, CVS says it's the only programme of its type in the veterinary sector.
The programme will be open to all of CVS's young vets and will operate within all 12 of its farm practices in the England, Scotland and Northern Ireland.
Each CVS farm graduate vet will be able to go on an exchange in their second year of the programme and every placement will last up to two weeks.
The subject matter of each exchange will be at the direction of the graduate rather than following a specific programme, so participating graduates have the freedom to explore their own areas of interest.
Anna Bruguera Sala, Programme Co-ordinator and vet at Alnorthumbria Farm Vets, said: “The major benefits of our new graduate exchange programme is that it is open to all young vets of different levels of experience and provides bespoke learning opportunities tailored to each individual.
"It will also create connections, so experienced colleagues can support an exchange student with their new skillset when they are back within their own practice.”
www.careerswithcvs.co.uk
Researchers from the University of Bristol have published the results of a study which has identified risk factors for syringomyelia (SM) and which could help breeders select away from characteristics which predispose dogs to the disease.
Syringomyelia, which more commonly affects toy breeds such as the Cavalier King Charles Spaniel and the Chihuahua, causes fluid-filled cavities in the spinal cord. In these toy breeds, SM is usually secondary to a specific malformation of the skull called Chiari-like Malformation (CM).
The research looked at the relationship between head shape and the incidence of CM/SM. Dogs were measured in several countries using a standardised "bony landmark" measuring system and photos analysed by researchers.
The researchers found two significant risk factors associated with CM/SM in the skull shape of the CKCS: brachycephaly (the broadness of the top of skull relative to its length) and the distribution of doming of the skull. The study suggests that brachycephaly, with resulting doming towards the front of the head, is associated with CM/SM.
Thomas Mitchell, the undergraduate student who conducted the study under the supervision of Dr Clare Rusbridge, said: "Dog breeders are very experienced at selecting for a certain conformation or appearance in dogs. Our findings may allow breeders to select away from the condition over fewer generations by choosing appropriate matings and offspring to continue breeding programmes. The identification of an appearance that might protect against developing the disease is a significant step forward in tackling this painful condition.
"The study also provides guidance to breed clubs, breeders and judges that have a responsibility to avoid obvious conditions or exaggerations which would be harmful in any way to the health, welfare or soundness of the breed. It will also provide vets with verified advice to provide to breeders outside the show ring and to occasional hobbyists."
The study has been published online in the journal Canine Genetics and Epidemiology, and a video animation which shows the differences in head shape is available on YouTube.
The work was funded by a grant from the Kennel Club Charitable Trust and the Companion Cavalier Club provided a grant for the publication of the research.
Reference
According to the charity, the fire broke out in an adjacent building in the early hours of the morning and caused considerable damage before it was put out by the fire brigade.
Luckily, the building was unoccupied at the time and nobody was hurt.
Structural damage was caused to the building and the charity reports that much of its office contents were damaged or destroyed by fire, smoke or water, including its servers.
However, because of coronavirus, the charity had already put systems in place to operate remotely, so it expects to continue service more or less as normal.
The survey asks EU nationals about their experience of practising in the UK since the referendum and will seek to find out what their career expectations and aspirations are now.
The survey will also ask how they feel that the RCVS has supported EU vets to practise in the UK since the transition period ended on 31 December 2020.
The survey is being conducted by the Institute for Employment Studies (IES), an independent, not-for-profit research institute.
Respondents are encouraged to be as open as possible, as individual responses will not be seen by the RCVS and all survey data will be analysed independently by IES.
Lizzie Lockett, RCVS CEO said: “We are hearing anecdotal feedback from EU veterinary professionals about the impact of the EU Exit on their working lives, but it is important for us to have direct feedback as evidence for our recommendations.
"I would encourage everyone who receives the survey to share their thoughts with us, as the feedback we receive from this and the previous surveys, will help us to plan what training, resources and support the professions need from us post-EU Exit."
Everyone eligible to take part in the survey is being sent an email today from Dilys Robinson at the IES, with a link to the survey.
You have until Tuesday 16th November 2021 to complete it.
If you have any questions, contact Sara.Butcher@employment-studies.co.uk.
Having sold Belgravia House – its Westminster offices since 1995 – to a private investor in March 2021 for £14.5m, RCVS Council agreed the purchase of the new building for £20.5m.
The additional cost has been funded from College reserves.
The new building is a converted Victorian warehouse with open-plan office space spread across six floors.
The new premises are large enough to accommodate more staff and for the College to host more meetings and events.
Alternatively, the space can be used for greater social distancing and hybrid working if needed.
The College says any unwanted space can be rented out.
Two existing tenants will continue to lease office space at the premises for the time being and some refurbishment work will need to be completed before the College and RCVS Knowledge teams can start moving in.
Following Council’s earlier decision to terminate the lease on Belgravia House at the end of March 2022, RCVS staff will continue to work either remotely, or in temporary office space leased from the workplace provider, WeWork, in Chancery Lane.
The College says this arrangement offers a significant saving over leasing back Belgravia House.
Chief Executive Lizzie Lockett said: “Like any property purchase, it has been an extremely long and difficult journey to get to this point, with many challenges to navigate along the way, but I am delighted that we are finally able to announce our new home.
“Whilst we will have to wait a while longer before we can enjoy everything 1-2 Hardwick Street has to offer, we are very much looking forward to welcoming members of the professions to visit our new offices, and being able to host a variety of meetings and new events there for them.
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
The Animal Health Trust has repeated its call for veterinary surgeons to take part in its survey study on breed differences in clinical features of canine hyperadrenocorticism.
40 veterinary surgeons have so far taken part in the survey, and preliminary results show that some breeds tend to present with fewer clinical signs than others, which fits with the study's initial hypothesis.
In addition, researchers say that the frequency of most of the clinical signs in dogs affected by hyperadrenocorticism, including polydipsia, polyuria, polyphagia, abdominal distention, alopecia, panting, comedones and muscle weakness, seem to be lower than previously reported in earlier studies published decades ago.
The AHT says it hopes the results of this study will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism. However, in order to progress the study and draw firm conclusions, more responses from veterinary surgeons are needed.
Michael Bennaim, veterinary surgeon at the AHT, said: "We need members of the veterinary profession to help us increase knowledge of this disease and to promote this study to their colleagues. The online questionnaire takes around 10 minutes to complete and all the information that is collected will be processed anonymously."
The AHT requests that the online questionnaire is completed for each case diagnosed with spontaneous hyperadrenocorticism . The questionnaire can be found at http://bit.ly/aht-cushing
Participants can request to be notified of the results of this study when available. Each questionnaire submitted has a chance to win a £100 Amazon voucher.
If you have any questions about the study, contact michael.bennaim@aht.org.uk.
The Society of Practising Veterinary Surgeons (SPVS) is putting out a last call to take part in the SPVS Salaries Survey 2015, open to everybody working in the veterinary profession.
The long-standing survey provides a benchmark for veterinary surgeons, nurses and support staff to see trends in pay and conditions. Designed to provide a complete picture of remuneration levels, the survey covers basic earnings, bonuses, dividends, overtime and benefits such as accommodation, car allowances, private medical insurance and pensions. It also includes questions on employment contracts, hours worked, out of hours and weekend working.
Peter Brown, SPVS Treasurer and author of the Salaries Survey said: “I have been compiling the survey results for a number of years but it never fails to enlighten me as to what is happening in the profession. I know it is also the go to reference guide when practices are recruiting to help ensure they are offering competitive salary packages.
“Participation in the survey is open to all and the more practices that take part, the more accurate and useful the information will be so we would urge everyone working in the veterinary profession to take a few minutes to complete the survey. It can be done online and the information is completely anonymous.”
To complete the survey online, visit www.spvs.org.uk or, for a printed version, telephone 01926 410545. The survey is open until 30 November 2015.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
Ceva Animal Health has launched a new travel size 20ml bottle of Feliway Spray to help cat owners keep their pet comfortable whilst travelling this summer.
To promote the launch Ceva is giving away thousands of prizes to Feliway customers, offering them the chance to win a top prize of a spa day at Champneys, cat carriers, soft toys and travel stickers, whilst stocks last. To take part, customers need to enter their unique pack code via the Feliway Facebook page to toss an online coin to see what they have won.
In addition, veterinary surgeries that purchase a 12 pack of the 20ml spray will get a second 12 pack free.
Julia Wood, product manager at Ceva said: "Transporting cats even short distances, for necessary trips to the vet, cattery or to a local show, can easily become a nightmare for both the cat and the owner. We've introduced the new travel size spray to make it even more convenient for cat owners when they are on the move and we hope the extra competition incentive will drive sales for veterinary clinics."
The President of the British Veterinary Association has written to the Badger Trust to clarify the BVA position on the pilot badger culls in England, stating that it will not be supporting the Trust's application for a judicial review.
The BVA Council agreed a position on the continuation of controlled shooting in the pilot areas on 16 April. The position states that the BVA could only support further culling using controlled shooting in the pilot areas if steps are taken to improve both its effectiveness and humaneness and if there is robust monitoring and collation of results and independent analysis and auditing by a non-governmental body. It also states that the BVA supports the Independent Expert Panel's (IEP) recommendations for improving effectiveness and humaneness and urges Defra to implement all the IEP's recommendations fully.
The BVA says that since 16 April, it has been in dialogue with Defra to seek assurances that these issues will be addressed, and those discussions are ongoing. It will not be taking a further position on the pilot culls until BVA Council has had the opportunity to consider Defra's plans in full, when they are made available.
In a press release dated 20th May, The Badger Trust CEO Dominic Dyer said: "It is not acceptable for the DEFRA Secretary of State to now push aside the concerns of both the Independent Expert Panel and the British Veterinary Association, by moving ahead with a further badger cull in Gloucestershire and Somerset this summer without any independent monitoring in place."
The BVA says it is concerned that this misrepresents its position, and has led to some media reports suggesting that the BVA has withdrawn its support for badger culling as part of the overall strategy to eradicate bovine TB. It has not. The BVA says it continues to believe that the TB eradication strategy for England will only be successful if we are able to use all of the available tools, including targeted, humane badger culling.
Ian also discusses the most effective treatment and prevention strategies: "“With surveys showing deworming frequencies below those recommended by ESCCAP and concerns surrounding over treatment of cats and dogs, there has never been a more important time to examine the importance of routine roundworm prevention. Without adequate control of Toxocara canis and Angiostronglyus vasorum, the impact on owners and their pets can be considerable."
The webinar can be viewed here: https://www.elearning.vet/watch/65
Preoperative fasting to reduce the likelihood of gastroesophageal reflux, regurgitation, emesis and aspiration of gastric contents during anaesthesia is routine, but research on the topic is currently thin on the ground.
The survey aims to obtain information on current preoperative fasting recommendations and protocols in dogs and cats which will enable the expansion of knowledge on common practice. Kat (pictured right) said: "It will also allow me to compare current practice to the literature to examine the use of evidence-based practice. It may also highlight areas requiring improvement in small animal practice to ensure patient health and welfare."
The anonymous questionnaire is aimed at a number of veterinary staff including registered veterinary surgeons, nurses, students, animal care assistants, veterinary care assistants and reception/administration staff, as all are involved in giving advice and instructions to clients on this topic.
Kat plans to share significant findings with the profession in due course.
To take part in the survey, visit: https://harper-adams.onlinesurveys.ac.uk/preoperative-fasting-duration-questionnaire
The survey will close on Friday 14th August 2020 at 5:00pm.
Please share this story with colleagues!
The company says both programmes will be delivered using a range of high-quality blended learning techniques, including interactive online lessons supported by notes and videos.
The Small Animal Surgery programme will offer ten practical sessions held at training centres.
Delegates for Improve’s new DL Certificate programmes get both a module tutor – a recognised Specialist - and a dedicated programme tutor to support them through the course.
Alison Babington MRCVS, Business Development Coordinator at Improve International (pictured right), said: "We recently set out our strategy to make the achievement of a postgraduate qualification a realistic goal for every veterinarian and the launch of these new DL programmes will help us to deliver on this goal. Our DL Small Animal Medicine Certificate was launched in January 2019 and has attracted veterinarians from around the world, who are keen to study for a programme in their own time at a place of their choosing.”
“The new DL Small Animal Surgery course focuses on soft tissue surgery in the first year and orthopaedics and spinal work in the second. Reflecting the latest thinking and techniques for small animal surgery, it offers an excellent platform for surgeons keen to extend their surgical capabilities. High-quality surgical videos will support every module which delegates will have access to throughout their programme.
“The Feline Practice programme offers an in-depth look at some of the more common medical and surgical issues affecting cats, as well as those which can be more challenging to diagnose and treat.”
Delegates for both programmes have the opportunity to progress to achieving a recognised qualification, General Practitioner Certificate (GPCert) or a Postgraduate Certificate (PgC).
To register, visit: https://www.improveinternational.com/uk/distance-learning.
At 9.00am on Thursday and 1.45pm on Friday, Dr Sam Taylor, Feline Specialist and academy lead at the International Society of Feline Medicine (ISFM), will present ‘feline pawsative’, a talk about about cat inappetence and the remedy offered by Mirataz.
At 11.20am on Thursday and 9.00am on Friday, Matt Gurney, clinical director at Anderson Moores will be sharing the latest developments in sedation in dogs including Zenalpha.
At 12.30pm on Thursday and 12.35pm on Friday, Andrew Waller (pictured right), chief scientific officer at Intervacc AB, will be discussing how to rein in the impact of strangles using Dechra’s new protein-based vaccine, Strangvac.
The CPD sessions are first come, first served, and Dechra says it expects the presentations to be well-attended, so it could be worth getting there a little early, although probably no need to pitch a tent outside the night before.
In addition to the UK, Vetigel will be marketed and distributed to veterinary surgeons throughout Europe and elsewhere via Veterinary Instrumentation's global distribution network.
Matt Lewis, Vice President of Sales at Cresilon said: "Our partnership with Veterinary Instrumentation will help us provide more veterinary surgeons with a revolutionary hemostatic gel that significantly improves the standard of care for pets and animals.
"Vetigel has been used by thousands of veterinarians thus far and helps veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes."
https://vetigel.comhttps://veterinary-instrumentation.co.uk
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
Intervet/Schering-Plough Animal Health has announced that it is to sponsor the Equine Business Management Strategies (EBMS) program, a targeted business education program developed for equine veterinary surgeons and practice professionals.
According the company, this 5-day course has proven very successful in the United States. It had its European kick-off in Amsterdam on August 22, 2010, where a group of almost forty equine practitioners from North America and Europe gathered to discuss and learn how to apply business principles in their day-to-day work. The program was chaired by Dr. Joop Loomans, an equine veterinary surgeon responsible for equine business management education at the Department of Equine Sciences of the Veterinary Faculty of Utrecht University (The Netherlands).
Course participants worked with international specialists on strategic planning, benchmarking, branding and change management to create strategic plans to implement at their practices, and to share their knowledge, experience and ideas.
Intervet/Schering Plough says the launch of Equine Business Management Strategies program exceeded expectations of participants, sponsor and organizers. The chance to look at the day-to-day practice from a different angle and to learn about things like benchmarking exercises, revenue analysis and branding was highly appreciated. Participant Jeremy Mantell from Liphook Equine Hospital in the UK said: "The EBMS has given me a clearer understanding of what I need to change and develop in my practice."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering-Plough Animal Health said: "We believe that running an equine practice is not based solely on technical and scientific skills but also on effective practice management. That is why our company has decided to support this initiative. Intervet/Schering-Plough Animal Health also continues its custom of providing not only innovating products, but also new, value-added services to strengthen its bond with veterinarians."
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.